|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 |
| (11) | Number of the document | 1802777 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05796604.6 |
| Date of filing the European patent application | 2005-09-15 | |
| (97) | Date of publication of the European application | 2007-07-04 |
| (45) | Date of publication and mention of the grant of the patent | 2012-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/032815 |
| Date | 2005-09-15 |
| (87) | Number | WO 2006/033933 |
| Date | 2006-03-30 |
| (30) | Number | Date | Country code |
| 611063 P | 2004-09-16 | US | |
| 226995 | 2005-09-14 | US |
| (72) |
IVERSEN, Patrick, L., US
STEIN, David, A., US
|
| (73) |
Sarepta Therapeutics, Inc.,
3450 Monte Villa Parkway, Suite 101, Bothell, Washington 98021,
US
|
| (54) | ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING SSRNA VIRAL INFECTION |
| ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING SSRNA VIRAL INFECTION |